Impact of chemotherapy on hypercalcemia in breast and lung cancer patients

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 9, 2012, Pages 4373-4378

  Hassan, Bassam Abdul Rasool ^a   Yusoff, Zuraidah Binti Mohd ^a   Hassali, Mohamed Azmi ^a   Othman, Saad Bin ^a   Weiderpass, Elisabete ^b,c,d  

^a SCHOOL OF PHYSICS   (Malaysia)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CANCER REGISTRY OF NORWAY   (Norway)

^d FOLKHÄLSAN RESEARCH CENTER   (Finland)

Author keywords

Breast cancer; Chemotherapy type; Hypercalcemia; Lung cancer; PTHrP

Indexed keywords

EID: 84874009323     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.9.4373     Document Type: Article

References (21)

1. Clines G (2011). Mechanisms and treatment of hypercalcemia of malignancy. Current Opinion Endocrinology, Diabetes and Obesity, 18, 339-46.
2. Dolan S (2005). Electrolyte abnormalities in 'The royal marsden hospital handbook of cancer chemotherapy', Eds Brighton D, Wood M, Elsevier, Churchill Livingstone, pp 205-08.
3. Drug Lib.COM (2010). Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium in 'Information Source: Amgen Information Obtained From Clinicaltrials', Eds. Gov on October 04. New York, Drug Lib.com; 2010.
4. Ericson K. Hypercalcemia (1999) in 'Gale encyclopedia of medicine', Eds Olendorf D, Jeryan C, Boyaden K. Gale Research, An International Thomson company, Farmington Hills, pp 1500-3.
5. Hartley S, Repaskey W, Rohde J (2012). What Is the Best Treatment of an Adult Patient with Hypercalcemia of Malignancy. Journal [serial on the Internet]. Date; July. 2012.
6. He Z, Naik SG, Rathnasabapathy C, et al (2008). Hypercalcemia of malignancy in the era of zolendronic acid and effective chemotherapy. J Clin Oncol, 26, 15.
7. Helft PR, Rudin CM (1999). Metabolic and electrolyte complications of malignancy. in 'Oncologic Therapies', Eds Vokes EE, Golomb HM, Springer-Verlag, Berlin Heidelberg, Chicago pp 244-257.
8. Henderson MA, Danks JA, Slavin JL, et al (2006). Parathyroid hormone-related protein localization in breast cancers predict improved prognosis, Cancer Research, 66, 2250-6.
9. Kanbay M, Huddam B, Guyener N, Bovaciolu S (2009). Metastatic Medulloblastoma Presented with Hypercalcemia, A Rare Case. The Internet Journal of Oncology, 13, 47.
10. Kelland LR. Cancer cell biology, drug action and resistance in 'The Royal Marsden Hospital Handbook of Cancer Chemotherapy', Eds. Brighton D, Wood M. Elsevier /Churchill Livingstone, London, 47.
11. Medicine net. Com. Chemotherapy and Cancer Treatment, Coping with Side Effects (2010). New York, Medicine net. Com. 2010. http://www.medicinenet.com/script/main/art.asp?articlekey=21716
12. Mundy GR (1990). Calcuim homeostasis: Hypercalcemia and hypocalcemia/General concepts of calcuim homeostasis. Cambridge. The University Press.
13. National Cancer Institute NCI (2010). Hypercalcemia, managment. New York: National Cancer Institute NCI, [updated 2010; cited]; Available from: http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/HealthProfessional/page5. 2010.
14. Oda N, Nakai A, Hayashi R, et al, (1998). Utility of measuring serum parathyroid hormone-related protein concentration in leukemic patients with hypercalcemia for assessing disease status. Eur J Endocrinol, 139, 323-9.
15. Swartout-corbeil D (2002). Hypercalcemia in 'Gale encyclopedia of cancer', Ed Thackery E. Gale group, Detroit, pp 516-518.
16. Swartout-corbeil D (2005). Hypercalcemia in 'Gale encyclopedia of cancer 2', Ed Longe JL. Gale group, Detroit, pp 579-581.
17. Tannehill-gregg S, Levine A, Nadella M (2006). The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice. Clinical and Experimental Metastasis, 23, 19-31.
18. Tovar Sepulveda VA, Shen X, Falzon M (2002). Intracrine PTHrP Protects against Serum Starvation-Induced Apoptosis and Regulates the Cell Cycle in MCF-7 Breast Cancer Cells. Endocrinology, 143, 596.
19. Ünal S, Durmaz E, Erkoçoglu M, et al (2008). The rapid correction of hypercalcemia at presentation of acute lymphoblastic leukemia using high-dose methylprednisolone. Turkish J Pediatrics, 50, 171-5.
20. World Health Organization (2010). Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects with Elevated Serum Calcium in 'Amgen Call Center', Eds. Italy, World Health Organization; 2010.
21. Wysolmerski JJ, Broadus AE (1994). Hypercalcemia of malignancy: The central role of parathyroid hormone-related protein. Ann Rev Med, 45, 189-200